patient care

1:52
ERIC’s first International Meeting and plans for the future
Paolo Ghia
1:11
Let me introduce you to ERIC: the European Research Initiative on CLL
Paolo Ghia
1:33
CAR T-cell therapy: on the way to success
Steven Rosen
1:01
Nuances of systemic lymphoma and CNS lymphoma
Bianca Santomasso
1:09
Non-hodgkin lymphoma advances in 2018
Steven Rosen
2:09
CAR-T super users: teams to closely monitor patients receiving CAR T-cells
Bianca Santomasso
2:03
The challenging field of hem-onc therapeutics
Steven Rosen
2:15
Management of cytokine release syndrome and neurotoxicity: an emerging need
Bianca Santomasso
1:29
Quality of life in cutaneous lymphoma patients: patient-reported outcomes
Pablo Ortiz
1:36
Midostaurin and quizartinib: improving survival and day-to-day life in AML
Alexander Perl
1:19
Challenges for access to CAR T-cell therapy
Torsten Haferlach
2:19
Advice about ALL treatment in the clinical setting
Torsten Haferlach
1:36
Uses of MRD in patients with multiple myeloma
Rafael Fonseca
3:17
A pharmacoeconomic analysis of multiple myeloma treatment
Rafael Fonseca
1:50
European-wide MRD screening should be available for all
Elizabeth Macintyre
6:40
Trial updates in R/R MM from ASCO: ARROW, MMY1001 & OPTIMISMM
Noopur Raje
The content of VJHemOnc is intended for healthcare professionals